SMC accepts MSD’s PREVYMIS®▼ for use in NHS Scotland
The Scottish Medicines Consortium (SMC) has accepted MSD's PREVYMIS®▼ (letermovir) for use within NHS Scotland for prophylaxis of cytomegalovirus (CMV) reactivation and disease in...
The EC approves Tecentriq in combination with Avastin
The European Commission approves Roche's Tecentriq in combination with Avastin and chemotherapy for the initial treatment of metastatic lung cancer Roche has announced that the...
AstraZeneca to present Farxiga CV data at ACC 2019
Data evaluating the cardiovascular (CV) effects of Farxiga (dapagliflozin), including hospitalisation for heart failure (hHF) in adults with type-2 diabetes (T2D) have been selected...
European marketing authorisation application for darolutamide
Orion Corporation and Bayer have announced that a European marketing authorisation application has been submitted for darolumatide. The companies have submitted the marketing authorisation application to the...
Alzheimer’s Society’s advice over hormone therapy ‘risk’
A study by researchers at University of Helsinki, published in the BMJ, suggested that long term use of oral hormone therapy could be associated...
NICE requests more evidence on blinatumomab for acute lymphoblastic leukaemia
The National Institute for Health and Care Excellence (NICE) has requested further evidence on blinatumomab for the treatment of adults with acute lymphoblastic leukaemia. The committee...
Software platform to accelerate pharma innovation launched
Linum Labs, a software development studio that builds blockchain-based solutions, has announced the launch of Molecule, a software platform and marketplace to accelerate innovation...
EMA accepts marketing authorisation application for XOSPATA (gilteritinib)
Astellas Pharma Inc has announced that the submission for a marketing authorisation application for the oral once-daily therapy XOSPATA (gilteritinib) for the treatment of...
Napp launches Pelmeg® a biosimilar of pegfilgrastim in the UK
Napp Pharmaceuticals Limited has announced the launch of Pelmeg® a biosimilar of pegfilgrastim in the UK, following European Commission (EC) approval in November 2018. Pelmeg®...
Ageing of medical workforce is growing trend
The NHS workforce is ageing and employers must do more to support older doctors, according to a new report by the British Medical Association...
Latest articles
Novo Nordisk presents oral semaglitude data at ENDO
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners on the positive patient outcomes that come from working together
The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Detecting and managing atrial fibrillation
The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Popular articles
Detecting and managing atrial fibrillation
The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)
Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics and precision medicine
How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Novo Nordisk presents oral semaglitude data at ENDO
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Addressing the skills shortage in life sciences
How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...